2 Stevia Extracts Gain GRAS Affirmation

VANCOUVERGLG Life Tech Corp. received its third GRAS no objection" letter from the U.S. Food and Drug Administration (FDA) for the use of its PureSTV and BlendSure stevia extracts in foods and beverages. The high-purity extracts both contain greater than 95% steviol glycosides.

RA (rebaudioside A) and STV (stevioside) are the two major components from the stevia plant, and the GLG R&D and production teams have been working on technologies and patents to produce both high-purity RA and STV stevia extracts since 2001. They found the combination of high-purity RA and STV together tastes better than either high-purity RA or high-purity STV on their own in many beverage and food applications.

We have received the first Letter of No Objection of RA 97 in 2010 and this milestone marks the second and third Letters of No Objection that GLG has received from the FDA and it affirms our long-term commitment to provide our customers with the highest quality standards of stevia extracts in the United States and around the world," said GLC CEO and Chairman Dr. Luke Zhang. I am very pleased that the three letters will allow our RA, STV and BlendSureTM to be utilized in many of our AN0CTM beverage and foods. We have found that the FDA GRAS standard is respected in many of our key international markets including China, and we will therefore be able to further leverage this major achievement in our international markets."